Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 1231

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 8
Chunk 1231
---
 notes 
     (122,553) 
     — 
  
    Changes in operating assets and liabilities: 

    Accrued interest income 
     14,901  
     (14,901)
  
    Prepaid expenses 
     (176,300) 
     46,675 
  
    Accounts payable and accrued expenses 
     313,741  
     166,115 
  
    Accounts payable and accrued expenses - related parties 
     (446) 
     (12,054)
  
    Accrued interest payable 
     (15,056) 
     110,453 
  
    Accrued interest payable - related parties 
     1,785  
     (98,135)
  
    Other assets 
     —  
     6,480 
  
    Change in operating lease asset and liabilities 
     286  
     16,001 
  
    Net cash used in operating activities 
     (7,327,230) 
     (5,581,147)

    CASH FLOWS FROM INVESTING ACTIVITIES: 

    Investment in marketable securities 
     (43,587) 
     (2,998,572)
  
    Proceeds from disposition of marketable securities 
     2,959,352  
     187,895 
  
    Purchase of equipment 
     —  
     (19,046)
  
    Net cash provided by (used in) investing activities 
     2,915,765  
     (2,829,723)

    CASH FLOWS FROM FINANCING ACTIVITIES: 

    Proceeds from note payable-related party 
     250,000  
     — 
  
    Repayment of note payable-related party 
     (59,730) 
     (685,473)
  
    Proceeds from convertible notes payable 
     790,000  
     3,935,000 
  
    Proceeds from issuance of common stock, warrants and pre-funded warrants, net of placement agent fees of $504,770 
     3,992,675  
     — 
  
    Payment of other issuance costs for issuance of common stock and equity-classified warrants 
     (235,707) 
     — 
  
    Payment for issuance costs related to liability-classified warrants 
     (28,477